Observed performance metrics in laboratory models
Observed performance metrics in laboratory models
Free shipping worldwide on all orders. This includes delivery to APO, DPO & FPO addresses.
Domestic: 5-7 business days.
International: 10-14 business days.
No express shipping due to timing inconsistencies from couriers.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript
Research summary on LGD-4033 (also known as Ligandrol or VK-5211).
Ostarine, also known as Enobosarm or MK-2866, is a non-steroidal selective androgen receptor modulator.
LGD-4033 (Ligandrol) is a Selective Androgen Receptor Modulator (SARM) — known for its potent anabolic activity in muscle and bone tissue.
In research settings, it has been shown to:
✔ Increase lean body mass even at low doses.
✔ Enhance muscle strength and endurance capacity.
✔ Aid recovery from musculoskeletal injury.
💥 MUSCLE HYPERTROPHY:
Clinical studies have shown LGD-4033 to significantly increase lean muscle mass in healthy adults within just weeks of administration.
🪨 STRENGTH GAINS:
Participants in research trials have demonstrated measurable improvements in lifting strength and muscular endurance.
🔄 RECOVERY SUPPORT:
By promoting anabolic signaling, LGD-4033 can aid in tissue repair following injury or intense training.
1.Angelis, Yiannis S, Sakellariou, Panagiotis, Petrou, Michael, & Pitsinos, Emmanuel N (2024). Targeted Metabolic Investigation of Ligandrol and Analytical Methods Validation for Its Main Long-term Metabolite.. ChemPlusChem.
https://doi.org/10.1002/cplu.202300634
2. Barbara, Mary, Dhingra, Sadhna, & Mindikoglu, Ayse L (2020). Ligandrol (LGD-4033)-Induced Liver Injury.. ACG case reports journal.
https://doi.org/10.14309/crj.0000000000000370
3. Basaria, Shehzad, Collins, Lauren, Dillon, E Lichar, Orwoll, Katie, Storer, Thomas W, Miciek, Renee, ... Bhasin, Shalender (2013). The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.. The journals of gerontology. Series A, Biological sciences and medical sciences.
https://doi.org/10.1093/gerona/gls078
4. Breuer, Johanna, Thomas, Andreas, Delahaut, Philippe, Schänzer, Wilhelm, Geyer, Hans, & Thevis, Mario (2023). Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry.. Analytical and bioanalytical chemistry.
https://doi.org/10.1007/s00216-022-04456-y
5. Cox, Holly D, & Eichner, Daniel (2017). Detection of LGD-4033 and its metabolites in athlete urine samples.. Drug testing and analysis.
Explore the best stack options.